Sierra Summit Advisors LLC Bristol Myers Squibb CO Transaction History
Sierra Summit Advisors LLC
- $462 Billion
- Q1 2025
A detailed history of Sierra Summit Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sierra Summit Advisors LLC holds 28,822 shares of BMY stock, worth $1.35 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
28,822
Previous 17,541
64.31%
Holding current value
$1.35 Million
Previous $992 Million
77.18%
% of portfolio
0.38%
Previous 0.2%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,736Shares Held
1.59BCall Options Held
26MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA191MShares$8.97 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.06 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.44 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.11 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.6B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...